Li BR - Search Results

1

G3BP2 promotes tumor progression and gemcitabine resistance in PDAC via regulating PDIA3-DKC1-hENT in a stress granules-dependent manner.

Xing FL, Li BR, Fang YJ, Liang C, Liu J, Wang W, Xu J, Yu XJ, Qin Y, Zhang B. Xing FL, et al. Among authors: li br. Acta Pharmacol Sin. 2024 Sep 17. doi: 10.1038/s41401-024-01387-5. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39289547

2

SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer.

Chen HD, Ye Z, Hu HF, Fan GX, Hu YH, Li Z, Li BR, Ji SR, Zhou CJ, Xu XW, Yu XJ, Qin Y. Chen HD, et al. Among authors: li br, li z. Acta Pharmacol Sin. 2024 Apr;45(4):844-856. doi: 10.1038/s41401-023-01199-z. Epub 2023 Dec 6. Acta Pharmacol Sin. 2024. PMID: 38057506

3

NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis.

Hu H, Li B, Chen H, Fan G, Ye Z, Ji S, Yu X, Xu X, Qin Y. Hu H, et al. Mol Carcinog. 2024 Feb;63(2):195-208. doi: 10.1002/mc.23645. Epub 2023 Oct 17. Mol Carcinog. 2024. PMID: 37846815

4

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer.

Li B, Xing F, Wang J, Wang X, Zhou C, Fan G, Zhuo Q, Ji S, Yu X, Xu X, Qin Y, Li Z. Li B, et al. Cancer Lett. 2024 Oct 10;602:217197. doi: 10.1016/j.canlet.2024.217197. Epub 2024 Aug 30. Cancer Lett. 2024. PMID: 39216548 Free article.

5

Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis.

Li B, Qin Y, Yu X, Xu X, Yu W. Li B, et al. Cell Prolif. 2022 Jan;55(1):e13167. doi: 10.1111/cpr.13167. Epub 2021 Dec 22. Cell Prolif. 2022. PMID: 34939255 Free PMC article. Review.

6

Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1.

Wang T, Hu Q, Li B, Fan G, Jing D, Xu J, Hu Y, Dang Q, Ji S, Zhou C, Zhuo Q, Xu X, Qin Y, Yu X, Li Z. Wang T, et al. Cell Prolif. 2024 Nov;57(11):e13694. doi: 10.1111/cpr.13694. Epub 2024 Jun 27. Cell Prolif. 2024. PMID: 38938061 Free PMC article.

7

Cancer immunometabolism: advent, challenges, and perspective.

Dang Q, Li B, Jin B, Ye Z, Lou X, Wang T, Wang Y, Pan X, Hu Q, Li Z, Ji S, Zhou C, Yu X, Qin Y, Xu X. Dang Q, et al. Mol Cancer. 2024 Apr 5;23(1):72. doi: 10.1186/s12943-024-01981-5. Mol Cancer. 2024. PMID: 38581001 Free PMC article. Review.

8

Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective cohort study.

Li Z, Zhuo Q, Li B, Liu M, Chen C, Shi Y, Xu W, Liu W, Ji S, Yu X, Xu X. Li Z, et al. World J Surg Oncol. 2024 Jan 2;22(1):1. doi: 10.1186/s12957-023-03277-2. World J Surg Oncol. 2024. PMID: 38169384 Free PMC article.

9

Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks.

Shi Y, Li Z, Li B, Chen H, Chen C, Ji S, Yu X, Xu X. Shi Y, et al. ANZ J Surg. 2024 Mar;94(3):380-386. doi: 10.1111/ans.18775. Epub 2023 Nov 20. ANZ J Surg. 2024. PMID: 37985579

10

Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score matching study.

Li Z, Xu W, Wang T, Li B, Chen C, Shi Y, Zhou C, Zhuo Q, Ji S, Liu W, Yu X, Xu X. Li Z, et al. Surg Endosc. 2024 Jul;38(7):3578-3589. doi: 10.1007/s00464-024-10868-x. Epub 2024 May 15. Surg Endosc. 2024. PMID: 38750173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters